Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RSV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07177508
What this trial is testing

First Year Impact of Nirsevimab on Paediatric Respiratory Syncytial Virus Infection and Hospitalisations in the Australian Capital Territory

Who this might be right for
Respiratory Syncytial Viral (RSV) InfectionRespiratory Syncytial Virus HospitalizationsRespiratory Syncytial Virus Prevention
Nicola Irwin 2,355
Not applicableUnknownNCT06259487
What this trial is testing

Coordinated Vaccination Against RSV and Influenza in Patients With Chronic Heart Failure and Its Impact on Prognosis.

Who this might be right for
Heart FailureRSV InfectionInfluenza+1 more
Wroclaw Medical University 250
Large-scale testing (Phase 3)Active Not RecruitingNCT07220109
What this trial is testing

A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus Given to Chinese Adults 18 to 59 Years of Age at Increased Risk of Respiratory Syncytial Virus Disease

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 750
Not applicableStudy completedNCT00593918
What this trial is testing

Innate Immunity and Respiratory Syncytial Virus (RSV) Infection in Children

Who this might be right for
Respiratory Syncytial Virus Infection
University of Wisconsin, Madison 91
Not applicableActive Not RecruitingNCT05864118
What this trial is testing

Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory Viruses

Who this might be right for
Respiratory Tract Infections
University of Nebraska 1,000
Not applicableNot Yet RecruitingNCT07015255
What this trial is testing

Assessing the Burden of Respiratory Syncytial Virus (RSV)

Who this might be right for
Respiratory Syncytial Virus (RSV) InfectionAcute Lower Respiratory Tract InfectionsBronchiolitis+2 more
Abu Dhabi Health Services Company 1,500
Large-scale testing (Phase 3)Study completedNCT04424316
What this trial is testing

A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy.

Who this might be right for
Respiratory Tract Infection
Pfizer 14,727
Early research (Phase 1)Study completedNCT04065698
What this trial is testing

Pharmacokinetics and Safety of RV521 Formulations

Who this might be right for
Respiratory Syncytial Virus Infections
Pfizer 9
Not applicableStudy completedNCT02273882
What this trial is testing

An Observational Study of Respiratory Syncytial Virus (RSV) Hospitalizations in Preterm Infants

Who this might be right for
Respiratory Syncytial Virus Hospitalizations
AstraZeneca 497
Not applicableActive Not RecruitingNCT06851806
What this trial is testing

Study of Palivizumab in Children With High Risk of Severe Respiratory Syncytial Virus (RSV) Disease

Who this might be right for
Respiratory Syncytial Virus (RSV)
AstraZeneca 21
Not applicableStudy completedNCT06977971
What this trial is testing

RSV Antibiotic Drivers And Resource-use

Who this might be right for
Respiratory Syncytial Virus InfectionsAntibiotic Stewardship in Community Hospitals
Dr. Behcet Uz Children's Hospital 209
Testing effectiveness (Phase 2)Looking for participantsNCT07734649
What this trial is testing

Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older

Who this might be right for
Respiratory Syncytial Virus ImmunizationHuman Metapneumovirus ImmunizationHealthy Volunteers
Sanofi 2,400
Early research (Phase 1)Study completedNCT02952339
What this trial is testing

Evaluating the Infectivity, Safety, and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine in RSV-Seronegative Infants and Children 6 to 24 Months of Age

Who this might be right for
Respiratory Syncytial Virus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 33
Not applicableUnknownNCT05618769
What this trial is testing

Towards Life-Long Healthy Lungs: A Multidisciplinary Follow-up Framework for Preterm Infants

Who this might be right for
Premature BirthRespiratory DiseaseRespiratory Tract Infections+11 more
Franciscus Gasthuis 330
Early research (Phase 1)Study completedNCT03227029
What this trial is testing

Evaluating the Infectivity, Safety, and Immunogenicity of Recombinant Live-Attenuated RSV Vaccines RSV ΔNS2/Δ1313/I1314L or RSV 276 in RSV-Seronegative Infants 6 to 24 Months of Age

Who this might be right for
Respiratory Syncytial Virus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 65
Not applicableActive Not RecruitingNCT06647654
What this trial is testing

Impact and Effectiveness of ABRYSVO® Vaccination During Pregnancy

Who this might be right for
Respiratory Syncytial VirusRespiratory Tract Diseases
Pfizer 1
Large-scale testing (Phase 3)Study completedNCT05127434
What this trial is testing

Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age

Who this might be right for
Respiratory Syncytial Virus
ModernaTX, Inc. 36,814
Early research (Phase 1)Study completedNCT02297594
What this trial is testing

Safety, Tolerability and PK Study of AK0529 in Healthy Human

Who this might be right for
Respiratory Syncytial Virus Infections
Shanghai Ark Biopharmaceutical Co., Ltd. 74
Early research (Phase 1)Ended earlyNCT02593851
What this trial is testing

Assess the Pharmacokinetics, Safety, and Tolerability of Multiple Doses of Orally Administered JNJ-53718678 in Infants Hospitalized With Respiratory Syncytial Virus (RSV) Infection

Who this might be right for
Respiratory Syncytial Virus InfectionsVirus Diseases
Janssen Sciences Ireland UC 45
Large-scale testing (Phase 3)Study completedNCT00129766
What this trial is testing

Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children

Who this might be right for
Respiratory Syncytial Virus Infections
MedImmune LLC 6,635
Next Page